CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
2,217,476
Share change
+16,071
Total reported value
$2,549,000
Price per share
$1.15
Number of holders
20
Value change
+$20,507
Number of buys
6
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2016

As of 31 Dec 2016, CASI PHARMACEUTICALS INC - COM (CASI) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,217,476 shares. The largest 10 holders included Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, RENAISSANCE TECHNOLOGIES LLC, Moors & Cabot, Inc., Raymond James Financial Services Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Fund Advisors. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.